The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs

BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium glucose co-transporter-2 (SGLT-2) inhibitors reduce cardiorenal outcomes. We performed a network meta-analysis to compare the effect on cardiorenal outcomes among GLP-1 RAs, SGLT-2 inhibitors and dipeptidyl peptidase-4 (DPP-4...

Descripción completa

Detalles Bibliográficos
Autores principales: Giugliano, Dario, Longo, Miriam, Signoriello, Simona, Maiorino, Maria Ida, Solerte, Bruno, Chiodini, Paolo, Esposito, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925229/
https://www.ncbi.nlm.nih.gov/pubmed/35296336
http://dx.doi.org/10.1186/s12933-022-01474-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925229/
https://www.ncbi.nlm.nih.gov/pubmed/35296336
http://dx.doi.org/10.1186/s12933-022-01474-z

Ejemplares similares